Human Papillomavirus Prevalence, Genotype Diversity, and Risk Factors Among Transgender Women and Nonbinary Participants in the P18 Cohort Study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Gender-Related Health Care Discrimination and Human Papillomavirus Vaccination Among Transgender and Nonbinary Young Adults in the United States.Transgender health · 2023
   Article
2. Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review.Open forum infectious diseases · 2023
   Review
3. Follow-Up to High-Resolution Anoscopy After Abnormal Anal Cytology in People Living with HIV.AIDS patient care and STDs · 2022
   Article
4. Human Papillomavirus Infection: Knowledge, Risk Perceptions and Behaviors among SMW and AFAB.Diagnostics (Basel, Switzerland) · 2022
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.